Glenmark Pharmaceuticals Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹3,473.21Cr |
Net Profits | ₹354.21Cr |
Net Profit Margins | 10.20% |
Highlights
Revenue:
Glenmark Pharmaceuticals Ltd’s revenue jumped 4.37% since last year same period to ₹3,473.21Cr in the Q2 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 6.03% jump in its revenue since last 3-months.
Net Profits:
Glenmark Pharmaceuticals Ltd’s net profit jumped 532.23% since last year same period to ₹354.21Cr in the Q2 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 4.1% jump in its net profits since last 3-months.
Net Profit Margins:
Glenmark Pharmaceuticals Ltd’s net profit margin jumped 514.13% since last year same period to 10.20% in the Q2 2024-2025. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -1.82% fall in its net profit margins since last 3-months.
